Head-to-head · free
CVS Health Corp. vs Doximity, Inc.
CVS vs DOCS — return on capital, cash generation, margins and balance sheet side by side.
CVS
3 / 10
measures where CVS leads
DOCS
7 / 10
measures where DOCS leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | CVS · FY2025 | DOCS · FY2026 |
|---|---|---|
| Revenue | $402.1B | $644.9M |
| Net income | $1.8B | $196.1M |
| Revenue growth (yearly, multi-year) | 8.3% | 17.0% |
| Free cash flow | $7.8B | $326.5M |
| Free cash flow margin | 1.9% | 50.6% |
| Net cash / (debt) | — | — |
| ROIC | 2.4% | 16.4% |
| Return on equity | 2.3% | 19.3% |
| Gross margin | 13.8% | 89.1% |
| Operating margin | 2.6% | 33.3% |
| Net debt / EBITDA | 6.06x | -0.96x |
Figures are as reported by each company; latest fiscal year shown.
Where CVS Health Corp.'s cash went (FY2025)
- Capital spending
- $2.8B
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Where Doximity, Inc.'s cash went (FY2026)
- Capital spending
- $0
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free